On Target Laboratories

http://www.ontargetlaboratories.com/
Tags:CenterDevelopmentDrugHealthInformationPharmacySpecialtyTechnologyUniversity
On Target Laboratories (OTL) is a West Lafayette, Indiana based specialty pharmaceutical company focused on the discovery and development of proprietary small molecules that target and illuminate cells, differentiating healthy from diseased tumor cells. This illumination enables surgeons to more accurately identify stage, surgically excise, treat and monitor diseases from cancer to auto-immune and inflammatory disease. The company’s technology is based on the pioneering work of Dr. Philip Low, the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University and Director of the Purdue University Center for Drug Discovery. The company’s lead asset, OTL38, is in a Phase 3 trial for ovarian cancer surgery and in a Phase 2 trial for lung cancer surgery. For more information visit:
Total raised: $21M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
24.03.2021Series B$21M--

Mentions in press and media 7

DateTitleDescriptionCategoryAuthorSource
24.03.2021On Target ...On Target Laboratories, Inc., ...USA-finsmes.co...
24.03.2021On Target ... WEST LAFAYETTE, Ind., March ...--prnewswire...
24.03.2021On Target ...---jnjinnovat...
29.11.20185 startup ...2018 is quickly drawing to its...-Pete Wilki...venturebea...
14.03.2018On Target ...On Target Laboratories, Inc., ...USA-finsmes.co...
14.03.2018H.I.G. Joi...On Target Laboratories, Inc., ...--citybizlis...
01.11.2017On Target ...---jnjinnovat...